Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition JR Vos, IE Fakkert, JA de Hullu, AM van Altena, AS Sie, H Ouchene, ... JNCI: Journal of the National Cancer Institute 112 (2), 161-169, 2020 | 64 | 2020 |
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening EH Gerkes, JM Fock, WFA den Dunnen, MJ van Belzen, CA van der Lans, ... Neurogenetics 17, 83-89, 2016 | 52 | 2016 |
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer IE Fakkert, EM Abma, IG Westrik, JD Lefrandt, BHR Wolffenbuttel, ... European Journal of Cancer 51 (3), 400-408, 2015 | 37 | 2015 |
Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers IE Fakkert, MJE Mourits, L Jansen, DM van der Kolk, K Meijer, ... Cancer Prevention Research 5 (11), 1291-1297, 2012 | 35 | 2012 |
Bone mineral density and fractures after surgical menopause: systematic review and meta‐analysis IE Fakkert, N Teixeira, EM Abma, RHJA Slart, MJE Mourits, GH de Bock BJOG: An International Journal of Obstetrics & Gynaecology 124 (10), 1525-1535, 2017 | 25 | 2017 |
Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify … JR Vos, IE Fakkert, L Spruijt, RW Willems, S Langenveld, ... International journal of cancer 147 (8), 2150-2158, 2020 | 22 | 2020 |
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy IE Fakkert, L Jansen, K Meijer, T Kok, JC Oosterwijk, MJE Mourits, ... Breast cancer research and treatment 129, 157-164, 2011 | 19 | 2011 |
Elevated bone turnover markers after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer IE Fakkert, E Van Der Veer, EM Abma, JD Lefrandt, BHR Wolffenbuttel, ... PloS one 12 (1), e0169673, 2017 | 15 | 2017 |
Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy N Teixeira, MJ Mourits, JC Oosterwijk, IE Fakkert, AR Absalom, ... Familial cancer 18, 19-27, 2019 | 9 | 2019 |
New multidisciplinary tasks in finding all Lynch Syndrome among patients with colorectal cancer below age 70 JR Vos, IE Fakkert, L Spruijt, RW Willems, S Langenveld, ... EUROPEAN JOURNAL OF HUMAN GENETICS 27, 1581-1581, 2019 | | 2019 |
Tumour DNA BRCA1/2 testing in newly diagnosed ovarian cancer as pre-selection for PARP inhibitor therapy and germline testing is feasible and effective N Hoogerbrugge, IE Fakkert, ID Nagtegaal, EM Leter, AR Mensenkamp, ... EUROPEAN JOURNAL OF HUMAN GENETICS 27, 453-453, 2019 | | 2019 |
Raising the age limit for routine MMR testing in colorectal cancer from 50 to 70 years improves recognition of new Lynch syndrome families N Hoogerbrugge, IE Fakkert, RW Willems, YK Peeks, S Langenveld, ... EUROPEAN JOURNAL OF HUMAN GENETICS 26, 90-91, 2018 | | 2018 |
BRCA testing in ovarian tumors initiated by a pathologist: a pre-screen for germline testing and therapy choice IE Fakkert, AR Mensenkamp, EM Leter, JA de Hullu, RW Willems, ... EUROPEAN JOURNAL OF HUMAN GENETICS 26, 528-529, 2018 | | 2018 |
Beyond risk-reducing salpingo-oophorectomy: On breast cancer risk and bone health IE Fakkert | | 2017 |
Beyond risk-reducing salpingo-oophorectomy IE Fakkert | | 2017 |
Breast cancer screening in and mutation carriers after risk reducing salpingo-oophorectomy IE Fakkert, L Jansen, K Meijer, T Kok, JC Oosterwijk, MJE Mourits, ... | | |
Breast cancer screening in women with hereditary elevated risk for breast and ovarian cancer after prophylactic bilateral salpingo-oophorectomy I Fakkert, VS Wetenschap | | |